132 related articles for article (PubMed ID: 9838551)
1. Bioequivalence study of Cipol-N (cyclosporine microemulsion preparation) in healthy adults.
Park MS; Yu NC; Kim YS; Lee HK; Kim KH
Transplant Proc; 1998 Nov; 30(7):3541-6. PubMed ID: 9838551
[No Abstract] [Full Text] [Related]
2. Neoral--a new microemulsion formula of cyclosporine A: interpatient pharmacokinetic variability in renal transplant recipients.
Klauser R; Irschik H; Kletzmayr J; Sturm I; Brunner W; Woloszczuk W; Kovarik J
Transplant Proc; 1995 Dec; 27(6):3427-9. PubMed ID: 8540034
[No Abstract] [Full Text] [Related]
3. Comparison of two microemulsion of cyclosporine A in healthy volunteers.
Tanasescu C; Serbanescu A; Spadaro A; Jen LH; Oliani C
Eur Rev Med Pharmacol Sci; 1999; 3(1):5-9. PubMed ID: 10710823
[TBL] [Abstract][Full Text] [Related]
4. Neoimmun versus Neoral: a bioequivalence study in healthy volunteers and influence of a fat-rich meal on the bioavailability of Neoimmun.
Kees F; Bucher M; Schweda F; Gschaidmeier H; Faerber L; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2007 Aug; 375(6):393-9. PubMed ID: 17571254
[TBL] [Abstract][Full Text] [Related]
5. Abbreviated AUC strategy for monitoring cyclosporine microemulsion therapy in the immediate posttransplant period.
Amante AJ; Kahan BD
Transplant Proc; 1996 Aug; 28(4):2162-3. PubMed ID: 8769187
[No Abstract] [Full Text] [Related]
6. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
Gentil Govantes MA; Gómez Ullate P; Errasti P; Fernández Fresnedo G; Capdevila L; Sanz Guajardo A; Cubero JJ
Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231
[No Abstract] [Full Text] [Related]
7. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers.
Piñeyro-López A; Piñeyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez-Silva M; Waksman N; E Salazar-Leal M; Luján-Rangel R
Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of oral cyclosporine microemulsion formulation (Neoral) in children awaiting renal transplantation.
Gusmano R; Basile GC; Perfumo F; Ginevri F; Verrina E; Famularo L; Corbetta G
Transplant Proc; 1998 Aug; 30(5):1985-7. PubMed ID: 9723362
[No Abstract] [Full Text] [Related]
9. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
Foradori A; Pinto VM; Elberg A
Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
Gaspari F; Anedda MF; Signorini O; Amuchastegui SC; Perico N; Remuzzi G
Transplant Proc; 1998 Aug; 30(5):1654-5. PubMed ID: 9723229
[No Abstract] [Full Text] [Related]
11. Area under the concentration curve values in pediatric liver transplant recipients on cyclosporin microemulsion formulation.
Dunn SP; Kulinsky A; Falkenstein K; Pierson A; Chang CT; Cooney GF
Transplant Proc; 1998 Aug; 30(5):1678-9. PubMed ID: 9723240
[No Abstract] [Full Text] [Related]
12. A review of absorption characteristics of microemulsion cyclosporine products over the last 2 years in Indian subjects.
Singh S; Sharma DR
J Indian Med Assoc; 1999 Mar; 97(3):114-7. PubMed ID: 10652912
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of cyclosporine microemulsion in Pakistani renal allograft recipients: correlation of trough peak levels with 7-point and 3-point AUC.
Hussain M; Zafar N; Bux A; Sultan S; Hashmi A; Hussain Z; Hafiz S; Naqvi A; Rizvi A
Transplant Proc; 1998 Nov; 30(7):3555. PubMed ID: 9838556
[No Abstract] [Full Text] [Related]
14. [Bioequivalence research of cyclosporin soft capsules].
Wu Y; Mao M; Wang L; Jiang X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):311-4, 331. PubMed ID: 22616181
[TBL] [Abstract][Full Text] [Related]
15. New cyclosporine microemulsion randomized, cross-over bioequivalence steady-state study in renal transplanted patients.
Sinescu I; Lopes HV; Foschi D; Jen LH; Oliani C
Eur Rev Med Pharmacol Sci; 1999; 3(1):11-8. PubMed ID: 10710824
[TBL] [Abstract][Full Text] [Related]
16. Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine.
Bökenkamp A; Offner G; Hoyer PF; Wonigeit K; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2273-5. PubMed ID: 8769223
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
Cooney GF; Lum BL; Meligeni JA; Dunn SP
Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222
[No Abstract] [Full Text] [Related]
18. Cyclosporine bioequivalence study: quantification using fluorescence polarization immunoassay (FPIA) and radioimmunoassay (RIA).
Mendes GD; de Oliveira CH; Sucupira M; Donato JL; Moreno RA; De Nucci G
Int J Clin Pharmacol Ther; 2004 Feb; 42(2):125-32. PubMed ID: 15180174
[TBL] [Abstract][Full Text] [Related]
19. Circadian variations in the pharmacokinetics of a new microemulsion formulation of cyclosporine in cardiac transplant recipients.
Châteauvert N; Côté H
Pharmacotherapy; 1998; 18(2):364-70. PubMed ID: 9545156
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two cyclosporine formulations in healthy volunteers: bioequivalence of the new Sang-35 formulation and Neoral.
Schroeder TJ; Cho MJ; Pollack GM; Floc'h R; Moran HB; Levy R; Moore LW; Pouletty P
J Clin Pharmacol; 1998 Sep; 38(9):807-14. PubMed ID: 9753208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
